RESUMO
INTRODUCTION: Multiple scales have been designed to stratify the severity and predict the prognosis in the initial evaluation of patients with aneurysmal subarachnoid hemorrhage (aSAH). Our study aimed to validate the most commonly used prognostic scales for aSAH in our population: Hunt-Hess, modified Hunt-Hess, World Federation of Neurosurgical Societies (WFNS), Prognosis on Admission of Aneurysmal Subarachnoid Hemorrhage (PAASH), and Barrow Aneurysm Institute (BAI) scales. METHODS: This study includes all aSAH cases treated at our institution between June 2019 and December 2020. We developed a retrospective cohort by reviewing medical records and radiologic images performed during hospitalization. The outcome was evaluated using the modified Rankin scale (mRS). It was defined as a poor outcome (mRS 4-5) and mortality (mRS 6). The ROC curves and the area under the curve (AUC) of each of the prognostic scales were calculated to evaluate their prognostic prediction capacity. RESULTS: A total of 142 patients were diagnosed with aSAH. A poor outcome occurred in 52.1% of the patients, whereas mortality was 27.5%. The AUC of the scales studied was similar and no significant difference was found between them for predicting a poor outcome (P = .709) or mortality (P = .715). CONCLUSION: We determined that the prognostic scales for aSAH had a similar predictive value for poor clinical outcomes and mortality in our institution, with no significant difference. Thus, we recommend the most simple and well-known scale used institutionally.
Assuntos
Hemorragia Subaracnóidea , Humanos , Prognóstico , Hemorragia Subaracnóidea/diagnóstico por imagem , Resultado do Tratamento , Estudos Retrospectivos , PeruRESUMO
Objetivo: Describir el perfil clínico y epidemiológico de los pacientes con diagnóstico de neurocisticercosis en dos hospitales de Chiclayo, Perú. Materiales y métodos: Estudio descriptivo, transversal y retrospectivo, realizado en los hospitales Almanzor Aguinaga Asenjo y Regional Lambayeque. Se revisaron 96 historias clínicas de pacientes con diagnóstico de neurocisticercosis atendidos en el año 2014. Resultados: La media de edad de los pacientes fue 42,8 ± 18,8 años, 52,1% fue de sexo femenino, 26% provenía de Chiclayo y 54,2% recibieron atención por primera vez. El síntoma de consulta más frecuente fue la cefalea, y a todos se les realizó algún método de diagnóstico por imágenes. La ubicación fue en su mayoría cerebral y el estadio más común fue el calcificado. El tratamiento más utilizado fueron los anticonvulsivantes y los analgésicos. Conclusiones: La neurocisticercosis afecta principalmente a la población económicamente activa, es más frecuente en mujeres y la manifestación clínica más común es la cefalea
Objective: To describe the clinical and epidemiological profile of patients diagnosed with neurocysticercosis at two hospitals in Chiclayo, Peru. Materials and methods:A descriptive, cross-sectional and retrospective study was performed at the Almanzor Aguinaga Asenjo Hospital and Lambayeque Regional Hospital. Ninety-six (96) medical records of patients attended in 2014 with a diagnosis of neurocysticercosis were reviewed. Results: The mean age of the patients was 42.8 ± 18.8 years old, 52.1% were female, 26% came from Chiclayo and 54.2% received care for the first time. The most common symptom leading to medical consultation was headache. All patients underwent a diagnostic imaging method. The location of the parasite was mostly in the brain and the calcified stage was the most common one. The most widely used treatments were anticonvulsants and pain relievers. Conclusions: Neurocysticercosis mainly affects the economically active population, is more common in women and the most common clinical manifestation is headache